InnoCore Pharmaceuticals Overview

  • Founded
  • 2004
Founded
  • Status
  • Private
  • Employees
  • 36
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $1.5M
Latest Deal Amount
  • Investors
  • 2

InnoCore Pharmaceuticals General Information

Description

Developer and manufacturer of long-acting injectable drug delivery products designed to help the treatment of chronic diseases. The company's products utilize its proprietary drug delivery technologies to develop biodegradable sustained release depots for precisely controlled delivery of therapeutic compounds, enabling clients to get innovative injectable and implantable drug delivery products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Primary Office
  • L.J. Zielstraweg 1
  • 9713 GX Groningen
  • Netherlands
+31 050 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

InnoCore Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 11-Sep-2020 $1.5M Completed Generating Revenue
1. Early Stage VC Completed Startup
To view InnoCore Pharmaceuticals’s complete valuation and funding history, request access »

InnoCore Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer and manufacturer of long-acting injectable drug delivery products designed to help the treatment of chronic di
Drug Delivery
Groningen, Netherlands
36 As of 2021
0000000000

00000000

cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in cul
0000000000000
San Diego, CA
00.00 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InnoCore Pharmaceuticals Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000000 00000000 Corporate Backed or Acquired San Diego, CA 000000&0
You’re viewing 1 of 1 competitors. Get the full list »

InnoCore Pharmaceuticals Patents

InnoCore Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2628931-T3 Multi-block segmented copolymers of biodegradable separate phases and release of biologically active polypeptides Active 09-Jul-2010 0000000000
ES-2527193-T3 Multi-block segmented copolymers of separate biodegradable phases and release of biologically active polypeptides Active 09-Jul-2010 0000000000
CA-2804601-C Biodegradable phase separated segmented multi block co-polymers and release of biologically active polypeptides Active 09-Jul-2010 0000000000
CA-2804601-A1 Biodegradable phase separated segmented multi block co-polymers and release of biologically active polypeptides Granted 09-Jul-2010 0000000000
US-9364442-B2 Biodegradable phase separated segmented multi block co-polymers and release of biologically active polypeptides Active 09-Jul-2010 A61K9/5031
To view InnoCore Pharmaceuticals’s complete patent history, request access »

InnoCore Pharmaceuticals Executive Team (3)

Name Title Board Seat Contact Info
Jaap Oostendorp Chief Executive Officer
Rob Steendam Ph.D Chief Technology Officer
You’re viewing 2 of 3 executive team members. Get the full list »

InnoCore Pharmaceuticals Board Members (1)

Name Representing Role Since
Jan Hendriks Ph.D Self Board Member 000 0000
To view InnoCore Pharmaceuticals’s complete board members history, request access »

InnoCore Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InnoCore Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital 000 0000 000000 0
RUG Holding Venture Capital Minority 000 0000 000000 0
To view InnoCore Pharmaceuticals’s complete investors history, request access »

InnoCore Pharmaceuticals Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 01-Dec-2017 0000000000 Drug Delivery 000 00000
InGell 01-Jan-2015 Corporate Drug Delivery 000 00000
To view InnoCore Pharmaceuticals’s complete investments and acquisitions history, request access »